An impairment of barrier size and charge selectivity of glomerular basement membrane in streptozotocin-induced diabetes and prevention by pharmacological therapy.
about
Proteinuria precedes podocyte abnormalities inLamb2-/- mice, implicating the glomerular basement membrane as an albumin barrierDisruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivityEffects of ACE inhibition and angiotensin II receptor blockade on glomerular basement membrane protein excretion and charge selectivity in type 2 diabetic patients.In mice, proteinuria and renal inflammatory responses to albumin overload are strain-dependent.
P2860
An impairment of barrier size and charge selectivity of glomerular basement membrane in streptozotocin-induced diabetes and prevention by pharmacological therapy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
An impairment of barrier size ...... on by pharmacological therapy.
@ast
An impairment of barrier size ...... on by pharmacological therapy.
@en
An impairment of barrier size ...... on by pharmacological therapy.
@nl
type
label
An impairment of barrier size ...... on by pharmacological therapy.
@ast
An impairment of barrier size ...... on by pharmacological therapy.
@en
An impairment of barrier size ...... on by pharmacological therapy.
@nl
prefLabel
An impairment of barrier size ...... on by pharmacological therapy.
@ast
An impairment of barrier size ...... on by pharmacological therapy.
@en
An impairment of barrier size ...... on by pharmacological therapy.
@nl
P2093
P356
P1433
P1476
An impairment of barrier size ...... on by pharmacological therapy.
@en
P2093
P304
P356
10.1007/S007950000011
P577
2000-01-01T00:00:00Z